Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Depreciation & Amortization (CF) (2016 - 2025)

Aethlon Medical filings provide 15 years of Depreciation & Amortization (CF) readings, the most recent being $83864.0 for Q1 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 2.29% to $83864.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $339559.0, a 5.43% decrease, with the full-year FY2025 number at $339559.0, down 5.43% from a year prior.
  • Depreciation & Amortization (CF) hit $83864.0 in Q1 2025 for Aethlon Medical, roughly flat from $83808.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $91473.0 in Q4 2023 to a low of $11164.0 in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $79542.0 (2023), compared with a mean of $63197.5.
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 644.52% in 2021 and later dropped 23.83% in 2022.
  • Aethlon Medical's Depreciation & Amortization (CF) stood at $17673.0 in 2021, then skyrocketed by 342.06% to $78126.0 in 2022, then rose by 17.08% to $91473.0 in 2023, then dropped by 8.38% to $83808.0 in 2024, then increased by 0.07% to $83864.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $83864.0 (Q1 2025), $83808.0 (Q4 2024), and $85827.0 (Q3 2024) per Business Quant data.